Kamada Ltd (KMDA) income statement
KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30
$8.07−0.09 (-1.10%)
Close on Nov 18, 2026Market cap $465.53MP/E –Yield –
Kamada Ltd income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 40.8%
- Operating margin
- 14.5%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 4.06
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 60.0%
Valuation
- P/E ratio
- –
- Price to sales
- 2.43
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?